The Mexican healthcare sector faced a complex week after the president denounced fund misappropriation by public institutions. Meanwhile, the Mexican Association of Insurance Institutions (AMIS) stated the country has the highest out of pocket medical expenditure of all OECD members.
In international news, investment for neglected diseases hits record high in 2017, pharmaceutical giants Roche and Novartis are preparing for a no-deal Brexit by stockpiling medications and problems keep coming for CRISPR-babies scientist. Also, in an effort to prevent the next flu pandemic, a British research team bred genetically modified chickens.
Before jumping into the news, don’t miss our Interview of the Week. Mexico Health Review talked to Grupo Empresarial MDF’s Miguel Velázquez about market opportunities for hospital infrastructure.
Ready for more? Check out what made the headlines over the past week.
AMIS informed that 41.4 percent of healthcare expenditure is out of pocket, doubling the OECD average of 20 percent.
In a speech in Hidalgo, President Andrés Manuel López Obrador denounced financial irregularities in medication purchases made by the public sector. He added that an “honest” use of public funds would allow to provide medication for the entire country.
Lack of government initiatives regarding the implementation of digital health solutions will lead to a five to 10-year delay in the adoption of said systems.
Global investment for neglected diseases, including HIV, tuberculosis and malaria, hit record high of US$3.5 billion in 2017.
Fear over a no-deal Brexit leads Novartis and Roche to stockpile medicines to ensure supply in the UK. The UK is expected to break with the EU on March 29, 2019.
He Jiankui, the Chinese scientist who made headlines globally for his role in the creation of the first CRISPR-edited babies, has been fired from the Southern University of Science and Technology (SUSTech). He is now under house arrest.
British scientists prepare for the next flu pandemic with genetically modified chickens. Their goal is to make chickens flu-resistant and eliminate the possibility of an influenza virus that can infect humans.